Seidel Miriam C, Powell Robert O, Zgibor Janice C, Siminerio Linda M, Piatt Gretchen A
University of Pittsburgh Medical Center, Braddock, Pennsylvania, USA.
Diabetes Care. 2008 Apr;31(4):684-9. doi: 10.2337/dc07-1869. Epub 2008 Feb 5.
The objective of this study was to determine if a community-based modified Diabetes Prevention Program Group Lifestyle Balance (GLB) intervention, for individuals with metabolic syndrome, was effective in decreasing risk for type 2 diabetes and cardiovascular disease (CVD) in an urban medically underserved community, and subsequently to determine if improvements in clinical outcomes could be sustained in the short term.
This nonrandomized prospective intervention study used a one-group design to test the effectiveness of a community-based GLB intervention. Residents from 11 targeted neighborhoods were screened for metabolic syndrome (n = 573) and took part in a 12-week GLB intervention (n = 88) that addressed safe weight loss and physical activity.
A marked decline in weight (46.4% lost > or = 5% and 26.1% lost or = 7%) was observed in individuals after completion of the intervention. Of these subjects, 87.5% (n = 28) and 66.7% (n = 12) sustained the 5% and 7% reduction, respectively, at the 6-month reassessment. Over one-third of the population (43.5%, n = 30) experienced improvements in one or more component of metabolic syndrome, and 73.3% (n = 22) sustained this improvement at the 6-month reassessment. Additional improvements occurred in waist circumference (P < 0.009) and blood pressure levels (P = 0.04) after adjustment for age, sex, race, mean number of GLB classes attended, and time.
Adults in an urban medically underserved community can decrease their risk for type 2 diabetes and CVD through participation in a GLB intervention, and short-term sustainability is feasible. Future research will include long-term follow-up of these subjects.
本研究的目的是确定针对患有代谢综合征的个体开展的基于社区的改良糖尿病预防计划——群体生活方式平衡(GLB)干预,在城市医疗服务不足社区中是否能有效降低2型糖尿病和心血管疾病(CVD)的风险,随后确定临床结局的改善在短期内是否能够维持。
这项非随机前瞻性干预研究采用单组设计来测试基于社区的GLB干预的有效性。对来自11个目标社区的居民进行代谢综合征筛查(n = 573),并让其中一部分(n = 88)参与为期12周的GLB干预,该干预涉及安全减重和身体活动。
干预完成后,观察到个体体重显著下降(46.4%的人减重≥5%,26.1%的人减重≥7%)。在这些受试者中,87.5%(n = 28)和66.7%(n = 12)在6个月的重新评估时分别维持了5%和7%的体重减轻。超过三分之一的人群(43.5%,n = 30)在代谢综合征的一个或多个组分上有所改善,73.3%(n = 22)在6个月的重新评估时维持了这种改善。在对年龄、性别、种族、参加GLB课程的平均次数和时间进行调整后,腰围(P < 0.009)和血压水平(P = 0.04)也有进一步改善。
城市医疗服务不足社区的成年人通过参与GLB干预可以降低2型糖尿病和CVD的风险,并且短期维持是可行的。未来的研究将包括对这些受试者的长期随访。